Fusarium keratitis on the rise in southern Europe: Implications of contact lens use and global warming


Por: Pérez-García, G, Cruz, NS, Carrasco, ZD, Lázaro-Rodríguez, V, Weingartshofer, RD, Arnal, MAG, García, AM, de Nadal, MC, Giménez, IL

Publicada: 1 sep 2025 Ahead of Print: 1 jun 2025
Resumen:
Objectives. - To evaluate the epidemiological and clinical characteristics of all cases of Fusarium spp. keratitis diagnosed in a southern European tertiary hospital over the last 20 years. To assess risk factors and prognostic determinants for Fusarium spp. keratitis. Methods. - In this case series, all cases of Fusarium spp. keratitis diagnosed at Hospital de la Santa Creu i Sant Pau, Barcelona, Spain between 2004 and 2023 were reviewed. Results. - Over 20 years, 7 cases of Fusarium spp. keratitis were detected. The initial tenyear period (2004-2013) accounted for one case, whereas six cases were diagnosed between 2013-2023. All patients related a history of contact lens use, and two had previous corneal diseases. All cultures were positive for Fusarium solani. Each case was treated with oral and topical voriconazole, three received topical natamycin and chlorhexidine, and five received intrastromal and intracameral medications. All cases required early penetrating keratoplasty. Three infection recurrences were reported, with two cases progressing to phthisis bulbi. In recurrent cases, antifungal treatment was started after 15 days, and therapeutic penetrating keratoplasty was delayed by 35.7 days. In cases without infection recurrence, the mean time to initiation of antifungal treatment was 9.7 days, and keratoplasty was performed after a mean delay of 26.7 days. Conclusions. - Fusarium keratitis is a serious ocular condition typically seen in tropical hot and humid areas. Its increase in temperate regions may be related to contact lens use and climate change. Prompt antifungal treatment, antifungal susceptibility testing, and early keratoplasty may be crucial for better outcomes. (c) 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Filiaciones:
Pérez-García, G:
 Hosp Santa Creu i St Pau, Dept Ophthalmol, St Antoni Maria Claret 167, Barcelona 08025, Spain

Cruz, NS:
 Hosp Santa Creu i St Pau, Dept Ophthalmol, St Antoni Maria Claret 167, Barcelona 08025, Spain

Carrasco, ZD:
 Hosp Santa Creu i St Pau, Dept Ophthalmol, St Antoni Maria Claret 167, Barcelona 08025, Spain

 Autonomous Univ Barcelona, Barcelona 08193, Spain

Lázaro-Rodríguez, V:
 Hosp Santa Creu i St Pau, Dept Ophthalmol, St Antoni Maria Claret 167, Barcelona 08025, Spain

Weingartshofer, RD:
 Hosp Santa Creu i St Pau, Dept Ophthalmol, St Antoni Maria Claret 167, Barcelona 08025, Spain

Arnal, MAG:
 Hosp Santa Creu i St Pau, Dept Ophthalmol, St Antoni Maria Claret 167, Barcelona 08025, Spain

García, AM:
 Hosp Santa Creu i St Pau, Dept Ophthalmol, St Antoni Maria Claret 167, Barcelona 08025, Spain

de Nadal, MC:
 Hosp Santa Creu i St Pau, Dept Ophthalmol, St Antoni Maria Claret 167, Barcelona 08025, Spain

Giménez, IL:
 Hosp Santa Creu i St Pau, Dept Ophthalmol, St Antoni Maria Claret 167, Barcelona 08025, Spain
ISSN: 01815512





JOURNAL FRANCAIS D OPHTALMOLOGIE
Editorial
MASSON EDITEUR, 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE, Francia
Tipo de documento: Article
Volumen: 48 Número: 7
Páginas:
WOS Id: 001522201300001
ID de PubMed: 40578182

MÉTRICAS